The DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
Abstract
Multiple sclerosis lesion activity concurs with the extent of inflammation, demyelination and axonal suffering. Pro-inflammatory myeloid cells contribute to lesion development, but the self-limiting nature of lesions implies as yet unidentified anti-inflammatory mechanisms. We addressed the hypothesis that myelin ingestion by myeloid cells induces a foamy appearance and confers anti-inflammatory function. First, we show that myelin-containing foam cells in multiple sclerosis lesions consistently express a series of anti-inflammatory molecules while lacking pro-inflammatory cytokines. Second, unique location-dependent cytokine and membrane receptor expression profiles imply functional specialization allowing for differential responses to micro-environmental cues. A novel human in vitro model of foamy macrophages functionally confirmed that myelin ingestion induces an anti-inflammatory programme. Foamy macrophages are unable to respond to prototypical inflammatory stimuli but do express molecules involved in suppression of inflammation. These findings provide novel insights into the mechanisms of lesion control and may open new roads to intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Here we show that TREM2 was highly expressed within active MS lesions by lipid-laden microglia/macrophages known to display an alternatively activated M2 profile and to promote the resolution of inflammation and clearance of myelin debris [5].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lesions with foamy microglia exhibited increased cholesterol esters (CEs) and triacylglycerols (TAG), consistent with their lipid-laden phenotype, which was confirmed by the neutral lipid staining Oil Red O (ORO)14,16”
From Foamy microglia link oxylipins to disease progression in multiple sclerosis (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This lack of classical pro-inflammatory signaling has been previously found in MS lesions by mass cytometry of microglia49 and matches the lipid-induced lysosomal phenotype described in other diseases14,18,50,51.”
From Foamy microglia link oxylipins to disease progression in multiple sclerosis (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which may potentially reflect metabolic reprogramming associated with the chronic nature of the lesion14,18,50.”
From Foamy microglia link oxylipins to disease progression in multiple sclerosis (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, foamy microglia/macrophages have also been described as anti-inflammatory or immunosuppressed14,18.”
From Foamy microglia link oxylipins to disease progression in multiple sclerosis (2026) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“lipid-laden microglia/macrophages are immunosuppressive (20)”
From Reduced Angiopoietin-Like 4 Expression in Multiple Sclerosis Lesions Facilitates Lipid Uptake by Phagocytes via Modulation of Lipoprotein-Lipase Activity (2019) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
The many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D. M., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,168
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158
Anti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature reviews. Immunology · doi:10.1038/nri915 · Cited by 879
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862
Research works printed but not linked: 1
- Chayen J, Bitensky L. Analysis of chemical components of cells and tissues; reactions for lipids. In: Practical histochemistry. Chichester: Wiley; 1991. p. 45.
Cited by
Sorted by citations
Items 101–200 of 357
Hendrickx, D. A. E., Koning, N., Schuurman, K. G., Strien, M. E. V., Eden, C. G. V., Hamann, J., & Huitinga, I. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827fd9e8 · Cited by 72
Myeloid cell responses after spinal cord injury
David, S., Kroner, A., Greenhalgh, A. D., Zarruk, J. G., & López‐Vales, R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.003 · Cited by 81
Hernangómez, M., Carrillo-Salinas, F. J., Mecha, M., Correa, F., Mestre, L., Loría, F., Feliú, A., Docagne, F., & Guaza, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130202911 · Cited by 77
Schweingruber, N., Haine, A., Tiede, K., Karabinskaya, A., van den Brandt, J., Wüst, S., Metselaar, J. M., Gold, R., Tuckermann, J. P., Reichardt, H. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101604 · Cited by 76
LRP1 expression in microglia is protective during CNS autoimmunity
Chuang, T.-Y., Guo, Y. X., Seki, S. M., Rosen, A. M., Johanson, D. M., Mandell, J. W., Lucchinetti, C. F., & Gaultier, A. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0343-2 · Cited by 74
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself
Burm, S. M., Peferoen, L. A. N., Zuiderwijk-Sick, E. A., Haanstra, K. G., Hart, B. A. ‘., van der Valk, P., Amor, S., Bauer, J., & Bajramovic, J. J. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0605-8 · Cited by 73
Self-citationMultiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination
Prineas, J. W., & Parratt, J. D. E. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab083 · Cited by 76
TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord
Church, J. S., Kigerl, K. A., Lerch, J. K., Popovich, P. G., & McTigue, D. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0353-16.2016 · Cited by 75
Microglia Ontology and Signaling
ElAli, A., & Rivest, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00072 · Cited by 75
Impaired plasticity of macrophages in X-linked adrenoleukodystrophy
Weinhofer, I., Zierfuss, B., Hametner, S., Wagner, M., Popitsch, N., Machacek, C., Bartolini, B., Zlabinger, G., Ohradanova-Repic, A., Stockinger, H., et al. (2018) · Brain · doi:10.1093/brain/awy127 · Cited by 72
Serafini, B., Magliozzi, R., Rosicarelli, B., Reynolds, R., Zheng, T. S., & Aloisi, F. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818dab90 · Cited by 72
López‐Vales, R., Navarro, X., Shimizu, T., Baskakis, C., Kokotos, G., Constantinou‐Kokotou, V., Stephens, D. L., Dennis, E. A., & David, S. (2008) · Brain · doi:10.1093/brain/awn188 · Cited by 71
Progressive multiple sclerosis
Bradl, M., & Lassmann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0182-3 · Cited by 108
Perilipin-2 limits remyelination by preventing lipid droplet degradation
Loix, M., Wouters, E., Vanherle, S., Dehairs, J., McManaman, J. L., Kemps, H., Swinnen, J. V., Haidar, M., Bogie, J. F. J., & Hendriks, J. J. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04547-0 · Cited by 70
Psenicka, M. W., Smith, B. C., Tinkey, R. A., & Williams, J. L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.654284 · Cited by 73
Targeting lipophagy in macrophages improves repair in multiple sclerosis
Haidar, M., Loix, M., Vanherle, S., Dierckx, T., Vangansewinkel, T., Gervois, P., Wolfs, E., Lambrichts, I., Bogie, J. F. J., & Hendriks, J. J. A. (2022) · Autophagy · doi:10.1080/15548627.2022.2047343 · Cited by 71
Immune response in peripheral axons delays disease progression in SOD1G93A mice
Nardo, G., Trolese, M. C., de Vito, G., Cecchi, R., Riva, N., Dina, G., Heath, P. R., Quattrini, A., Shaw, P. J., Piazza, V., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0732-2 · Cited by 69
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation
Sosa, R. A., Murphey, C. L., Robinson, R. R., & Forsthuber, T. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505955112 · Cited by 70
Traumatic Brain Injury: An Age-Dependent View of Post-Traumatic Neuroinflammation and Its Treatment
Delage, C., Taib, T., Mamma, C., Lerouet, D., & Besson, V. C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101624 · Cited by 72
Brendecke, S. M., & Prinz, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0520-6 · Cited by 68
Multiple sclerosis – a response-to-damage model
Hart, B. A. ‘., Hintzen, R. Q., & Laman, J. D. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.04.001 · Cited by 66
Self-citationProteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis
Fabriek, B. O., Møller, H. J., Vloet, R. P. M., van Winsen, L. M. L., Hanemaaijer, R., Teunissen, C. E., Uitdehaag, B. M. J., van den Berg, T. K., & Dijkstra, C. D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.04.016 · Cited by 65
Dibaj, P., Steffens, H., Zschüntzsch, J., Nadrigny, F., Schomburg, E. D., Kirchhoff, F., & Neusch, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017910 · Cited by 67
Zahoor, I., Suhail, H., Datta, I., Ahmed, M. E., Poisson, L., Waters, J., Rashid, F., Rui, B., Singh, J., Cerghet, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123265119 · Cited by 62
The Unique Phenotype of Lipid-Laden Macrophages
van Eijk, M., & Aerts, J. M. F. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084039 · Cited by 63
Self-citationDifferential responses of human microglia and blood-derived myeloid cells to FTY720
Durafourt, B. A., Lambert, C., Johnson, T., Blain, M., Bar‐Or, A., & Antel, J. P. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.006 · Cited by 63
Brennan, F. H., & Popovich, P. G. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000550 · Cited by 63
Evoked potentials as a biomarker of remyelination
Heidari, M., Radcliff, A. B., McLellan, G. J., Hoeve, J. N. V., Chan, K., Kiland, J. A., Keuler, N. S., August, B. K., Sebo, D. J., Field, A. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906358116 · Cited by 65
Neuroimmune interactions and immunoengineering strategies in peripheral nerve repair
Wofford, K. L., Shultz, R. B., Burrell, J. C., & Cullen, D. K. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102172 · Cited by 64
Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?
Pineda‐Torra, I., Siddique, S., Waddington, K. E., Farrell, R. A., & Jury, E. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639757 · Cited by 63
Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1
Dardis, A., Michelakakis, H., Rozenfeld, P., Fumic, K., Wagner, J., Pavan, E., Fuller, M., Revel-Vilk, S., Hughes, D., Cox, T., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02573-6 · Cited by 61
Self-citationMyelin and non-myelin debris contribute to foamy macrophage formation after spinal cord injury
Ryan, C. B., Choi, J. S., Al‐Ali, H., & Lee, J. K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105608 · Cited by 59
Jaisinghani, N., Dawa, S., Singh, K., Nandy, A., Menon, D., Bhandari, P. D., Khare, G., Tyagi, A. K., & Gandotra, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01490 · Cited by 58
Chemical and genetic control of IFNγ‐induced MHCII expression
Wijdeven, R. H. M., van Luijn, M. M., Wierenga‐Wolf, A. F., Akkermans, J. J. L. L., van den Elsen, P. J., Hintzen, R. Q., & Neefjes, J. (2018) · EMBO Reports · doi:10.15252/embr.201745553 · Cited by 59
Self-citationMyelin-phagocytosing macrophages modulate autoreactive T cell proliferation
Bogie, J. F. J., Stinissen, P., Hellings, N., & Hendriks, J. J. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-85 · Cited by 62
Rao, X., Zhong, J., & Sun, Q. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.09.015 · Cited by 58
The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions
Park, C., Ponath, G. D., Levine-Ritterman, M., Bull, E., Swanson, E. C., Jager, P. L. D., Segal, B. M., & Pitt, D. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0779-2 · Cited by 55
Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System
Ivan, D. C., Walthert, S., Berve, K., Steudler, J., & Locatelli, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609921 · Cited by 55
Min, H., Jang, Y. H., Cho, I., Yu, S., & Lee, S. J. (2016) · Molecular Brain · doi:10.1186/s13041-016-0225-3 · Cited by 55
Interdependence of oxysterols with cholesterol profiles in multiple sclerosis
Mukhopadhyay, S., Fellows, K., Browne, R. W., Khare, P., Radhakrishnan, S. K., Hagemeier, J., Weinstock‐Guttman, B., Zivadinov, R., & Ramanathan, M. K. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516666187 · Cited by 53
Hendriks, J. J. A., Slaets, H., Carmans, S., de Vries, H. E., Dijkstra, C. D., Stinissen, P., & Hellings, N. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.015 · Cited by 60
Lipophagy: a new player in CNS disorders
Haidar, M., Loix, M., Bogie, J. F. J., & Hendriks, J. J. A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.08.010 · Cited by 55
Hammel, G., Zivkovic, S., Ayazi, M., & Ren, Y. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104591 · Cited by 55
Glial regulation of the blood-brain barrier in health and disease
Broux, B., Gowing, E., & Prat, A. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0516-2 · Cited by 53
Hamamcıoğlu, K., & Reder, A. T. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506069672 · Cited by 52
The impact of ATP-binding cassette transporters in the diseased brain: Context matters
Baltira, C., Aronica, E., Elmquist, W. F., Langer, O., Löscher, W., Sarkaria, J. N., Wesseling, P., de Gooijer, M. C., & van Tellingen, O. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101609 · Cited by 54
Herder, V., Iskandar, C. D., Kegler, K., Hansmann, F., Elmarabet, S. A., Khan, M. A., Kalkuhl, A., Deschl, U., Baumgärtner, W., Ulrich, R., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12238 · Cited by 50
Dendritic Cell Differentiation Signals Induce Anti-Inflammatory Properties in Human Adult Microglia
Lambert, C., Desbarats, J., Arbour, N., Hall, J. A., Olivier, A., Bar-Or, A., & Antel, J. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8288 · Cited by 50
Han, D., Yu, Z., Liu, W., Yin, D., Pu, Y., Feng, J., Yuan, Y., Huang, A., Cao, L., & He, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0236-8 · Cited by 49
Pul, R., Morbiducci, F., Škuljec, J., Skripuletz, T., Singh, V., Diederichs, U., Garde, N., Voß, E. V., Trebst, C., & Stangel, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051867 · Cited by 47
Remyelination in multiple sclerosis: Cellular mechanisms and novel therapeutic approaches
Olsen, J. A., & Akirav, E. M. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23493 · Cited by 51
Borucki, D. M., Toutonji, A., Couch, C., Mallah, K., Rohrer, B., & Tomlinson, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566892 · Cited by 46
Berard, J. L., Kerr, B. J., Johnson, H. M., & David, S. (2010) · Glia · doi:10.1002/glia.21051 · Cited by 46
Pulli, B., Buré, L., Wojtkiewicz, G. R., Iwamoto, Y., Ali, M. Y. J., Li, D., Schob, S., Hsieh, K. L., Jacobs, A. H., & Chen, J. W. (2014) · Radiology · doi:10.1148/radiol.14141495 · Cited by 48
Venosa, A., Smith, L. C., Murray, A., Banota, T., Gow, A. J., Laskin, J. D., & Laskin, D. L. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz187 · Cited by 46
Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation
Tsuyama, J., Nakamura, A., Ooboshi, H., Yoshimura, A., & Shichita, T. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0707-8 · Cited by 45
Immunomodulation by statins: Inhibition of cholesterol vs. isoprenoid biosynthesis
Kuipers, H. F., & van den Elsen, P. J. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.06.005 · Cited by 45
Active liver X receptor signaling in phagocytes in multiple sclerosis lesions
Mailleux, J., Vanmierlo, T., Bogie, J. F. J., Wouters, E., Lütjohann, D., Hendriks, J. J. A., & van Horssen, J. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517696595 · Cited by 49
Axonal regeneration in zebrafish spinal cord
Ghosh, S., & Hui, S. P. (2018) · Regeneration · doi:10.1002/reg2.99 · Cited by 46
Targeting senescence to delay progression of multiple sclerosis
Oost, W., Talma, N., Meilof, J. F., & Laman, J. D. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1686-x · Cited by 47
Self-citationZhou, Q., Xiang, H., Li, A., Wu, L., Huang, Z., Guo, J., Wang, P., Chi, Y., Xiang, K., Xu, Y., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5783 · Cited by 44
Multiple Sclerosis: Destruction and Regeneration of Astrocytes in Acute Lesions
Prineas, J. W., & Lee, S. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly121 · Cited by 47
Pathology of inflammatory diseases of the nervous system: Human disease versus animal models
Lassmann, H. (2019) · Glia · doi:10.1002/glia.23726 · Cited by 44
Immunological mechanisms in poststroke dementia
Doyle, K. P., & Buckwalter, M. S. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000783 · Cited by 42
The therapeutic potential of bone marrow‐derived macrophages in neurological diseases
Zhou, K., Han, J., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13964 · Cited by 44
Zhou, L., Dong, M., Hu, Z., Tang, Y., Chu, Y., Chen, M., Yang, S., Chen, Z., Wu, L., Wang, W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209990120 · Cited by 42
Nichols, J. M., Kummari, E., Sherman, J., Yang, E.-J., Dhital, S., Gilfeather, C., Yray, G., Morgan, T., & Kaplan, B. L. F. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09917-8 · Cited by 42
Radandish, M., Khalilian, P., & Esmaeil, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667705 · Cited by 41
Age Influences Microglial Activation After Cuprizone-Induced Demyelination
Klein, B., Mrowetz, H., Barker, C. M., Lange, S., Rivera, F. J., & Aigner, L. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00278 · Cited by 44
d -mannose suppresses oxidative response and blocks phagocytosis in experimental neuroinflammation
Wang, J., Motlagh, N. J., Wang, C., Wojtkiewicz, G. R., Schmidt, S., Chau, C., Narsimhan, R. P., Kuellenberg, E. G., Zhu, C., Linnoila, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107663118 · Cited by 41
Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes
Natrajan, M. S., Komori, M., Kosa, P. F., Johnson, K. R., Wu, T., Franklin, R. J. M., & Bielekova, B. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.260 · Cited by 40
Sunil, V. R., Francis, M., Vayas, K. N., Cervelli, J. A., Choi, H., Laskin, J. D., & Laskin, D. L. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.002 · Cited by 40
Imaging Neuroinflammation – from Bench to Bedside
Pulli, B. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000226 · Cited by 41
Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
Poppell, M., Hammel, G., & Ren, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065925 · Cited by 39
Cholesterol in the CNS: functions, recycling and remyelination
Wuerch, E. C., & Yong, V. W. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03490-8 · Cited by 41
Shakhbazau, A., Mishra, M. K., Chu, T., Brideau, C., Cummins, K., Tsutsui, S., Shcharbin, D., Majoral, J., Mignani, S. M., Blanchard-Desce, M. H., et al. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500150 · Cited by 39
Prins, M., Eriksson, C., Wierinckx, A., Bol, J. G. J. M., Binnekade, R., Tilders, F. J. H., & van Dam, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083835 · Cited by 37
Alternative macrophage activation in periprosthetic osteolysis
Purdue, P. E. (2008) · Autoimmunity · doi:10.1080/08916930701694626 · Cited by 37
Biomarkers for Microglial Activation in Alzheimer′s Disease
Lautner, R., Mattsson, N., Schöll, M., Augutis, K., Blennow, K., Olsson, B., & Zetterberg, H. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/939426 · Cited by 38
Chen, Y., Zhang, Z.-X., Zheng, L., Wang, L., Liu, Y.-F., Yin, W.-Y., Chen, Y., Wang, X., Hou, S., Chen, J., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104490 · Cited by 37
Mangalam, A. K., Rattan, R., Suhail, H., Singh, J., Hoda, M. N., Deshpande, M., Fulzele, S., Đenić, A., Shridhar, V., Kumar, A., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501549 · Cited by 34
Kopper, T. J., Zhang, B., Bailey, W. M., Bethel, K. E., & Gensel, J. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-85863-6 · Cited by 40
Peferoen, L. A. N., Gerritsen, W. H., Breur, M., Ummenthum, K. M. D., Peferoen-Baert, R. M. B., van der Valk, P., van Noort, J. M., & Amor, S. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0267-2 · Cited by 36
Self-citationTrebst, C., König, F. B., Ransohoff, R. M., Brück, W., & Stangel, M. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508089359 · Cited by 35
A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis
Airas, L. M., Bermel, R. A., Chitnis, T., Hartung, H., Nakahara, J., Stüve, O., Williams, M. J., Kieseier, B. C., & Wiendl, H. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241233041 · Cited by 40
Moreno, M. A., Burns, T., Yao, P., Miers, L., Pleasure, D., & Soulika, A. M. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.11.004 · Cited by 34
Lipid-Laden Macrophages in Pulmonary Diseases
Zhu, Y., Choi, D., Somanath, P. R., & Zhang, D. (2024) · Cells · doi:10.3390/cells13110889 · Cited by 35
The gut-brain axis and beyond: Microbiome control of spinal cord injury pain in humans and rodents
Bannerman, C. A., Douchant, K., Sheth, P. M., & Ghasemlou, N. (2020) · Neurobiology of Pain · doi:10.1016/j.ynpai.2020.100059 · Cited by 34
Vanherle, S., Jorissen, W., Dierckx, T., Loix, M., Grajchen, E., Mingneau, F., Guns, J., Gervois, P., Lambrichts, I., Dehairs, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111591 · Cited by 31
Boraschi, D., Italiani, P., Migliorini, P., & Bossù, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128190 · Cited by 38
Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models
Fan, X., Zhang, H., Cheng, Y., Jiang, X., Zhu, J., & Jin, T. (2016) · Mediators of Inflammation · doi:10.1155/2016/8489251 · Cited by 34
M1 macrophages impair tight junctions between endothelial cells after spinal cord injury
Luo, Y., Yao, F., Hu, X., Li, Y., Chen, Y., Li, Z., Zhu, Z., Yu, S., Tian, D., Cheng, L., et al. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.12.019 · Cited by 34
Skripuletz, T., Miller, E., Grote, L., Gudi, V., Pul, R., Voss, E., Škuljec, J., Moharregh-Khiabani, D., Trebst, C., & Stangel, M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.05.009 · Cited by 31
Shimizu, T., Durose, W. W., Li, J., Abe, M., Sakimura, K., Chetsawang, B., Sahara, Y., Tohyama, K., Tanaka, K. F., & Ikenaka, K. (2017) · Glia · doi:10.1002/glia.23134 · Cited by 34
Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS‐275
Zierfuss, B., Weinhofer, I., Buda, A., Popitsch, N. P., Hess, L., Moos, V., Hametner, S., Kemp, S., Köhler, W., Forss‐Petter, S., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51200 · Cited by 30
Nardo, G., Trolese, M. C., & Bendotti, C. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00089 · Cited by 32
Heidbrink, C. H. C., Häusler, S. F., Buttmann, M., Ossadnik, M., Strik, H. M., Keller, A., Buck, D., Verbraak, E., van Meurs, M., Krockenberger, M., et al. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.04.003 · Cited by 30
Self-citationMyelin debris phagocytosis in demyelinating disease
Gao, R., Song, S., Tian, M., Wang, L., Zhang, Y., & Li, X. (2024) · Glia · doi:10.1002/glia.24602 · Cited by 31
Multiple sclerosis: The resolving lesion revealed
Raine, C. S. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.05.021 · Cited by 29
Corrales, A. V. G., Verberk, S. G. S., Haidar, M., Grajchen, E., Dehairs, J., Vanherle, S., Loix, M., Weytjens, T., Gervois, P., Matsuzaka, T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2301030120 · Cited by 30
Metadata
- Authors
- Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D.
- Affiliations
- Erasmus MC (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Biomedical Primate Research Centre (NL)
- Corresponding author
- Boven, Leonie A.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-19
- Volume
- 129
- Issue
- 2
- Pages
- 517-526
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2166298859
- Cited by
- 353
- References
- 50
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 19 · 2023: 13 · 2022: 17 · 2021: 26 · 2020: 20 · 2019: 21 · 2018: 25 · 2017: 13 · 2016: 21 · 2015: 29 · 2014: 28 · 2013: 17 · 2012: 11
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- multiple sclerosis, foam cells, anti-inflammatory macrophages, myeloid cells, demyelination, cytokine expression, cell surface receptors, in vitro macrophage model, neuroinflammation
- MeSH terms
- Brain, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Humans, Immunohistochemistry, Macrophages, Myelin Sheath, RNA, Messenger, Sialoglycoproteins, Biomarkers, Interleukin-4, Transforming Growth Factor beta, Interleukin-10, Chemokines, CC, Reverse Transcriptase Polymerase Chain Reaction, Multiple Sclerosis, Relapsing-Remitting, Interleukin 1 Receptor Antagonist Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
